Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F3TI
|
||||
Former ID |
DIB004478
|
||||
Drug Name |
PT-630
|
||||
Synonyms |
Non insulin dependent diabetes therapy, DARA BioSciences; Non insulin dependent diabetes therapy, Point Therapeutics
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Terminated | [548125] | ||
Company |
DARA BioSciences Inc
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Modulator | [556264] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.